VERA THERAPEUTICS INC's ticker is VERA and the CUSIP is 92337R101. A total of 52 filers reported holding VERA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $40,527,487 | -15.8% | 2,956,053 | -1.5% | 6.63% | +0.1% |
| Q2 2023 | $48,150,000 | +84.0% | 3,000,000 | -11.0% | 6.62% | +96.0% |
| Q1 2023 | $26,170,041 | -4.0% | 3,372,428 | +139.3% | 3.38% | -19.2% |
| Q4 2022 | $27,266,046 | -16.7% | 1,409,098 | -8.3% | 4.18% | -39.4% |
| Q3 2022 | $32,736,000 | +58.0% | 1,536,181 | +0.9% | 6.90% | +30.3% |
| Q2 2022 | $20,724,000 | +75.6% | 1,522,712 | +203.1% | 5.29% | +38.2% |
| Q1 2022 | $11,800,000 | +74.2% | 502,328 | +98.2% | 3.83% | +5.7% |
| Q4 2021 | $6,772,000 | – | 253,449 | – | 3.62% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 2,960,231 | $40,289,000 | 12.90% |
| Kynam Capital Management, LP | 1,522,712 | $20,724,000 | 5.29% |
| Sofinnova Investments, Inc. | 3,181,442 | $43,299,000 | 3.61% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,825 | $281,057,000 | 2.93% |
| Octagon Capital Advisors LP | 575,000 | $7,826,000 | 2.09% |
| Vivo Capital, LLC | 666,666 | $9,073,000 | 0.91% |
| RA Capital Management | 1,578,820 | $21,488,000 | 0.57% |
| Alphabet Inc. | 301,580 | $4,105,000 | 0.22% |
| CARNEGIE MELLON UNIVERSITY | 16,060 | $219,000 | 0.11% |
| Polar Asset Management Partners Inc. | 294,300 | $4,005,000 | 0.05% |